Home The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation
Article
Licensed
Unlicensed Requires Authentication

The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation

  • Susan J. Thorpe EMAIL logo , Alan Heath , Bernard Fox , Dina Patel and William Egner
Published/Copyright: May 7, 2014

Abstract

Background: The measurement of serum IgE aids in the diagnosis and management of atopic allergic disease and hyper-IgE immunodeficiency syndromes. The 2nd World Health Organization (WHO) International Reference Reagent (IRR) for serum IgE (75/502; 5000 IU/ampoule), is widely used to calibrate assays for serum IgE. Exhaustion of stocks of the 2nd IRR necessitated the production of a replacement preparation and its evaluation in an international collaborative study to determine its suitability to serve as the 3rd International Standard (IS) for serum IgE.

Methods: Sera and defibrinated plasma with elevated IgE levels were pooled and lyophilised in ampoules. This preparation, coded 11/234, was assayed by 18 laboratories in 11 countries using commercial assay methodology for IgE, along with the 2nd IRR, 75/502, and two lyophilised serum samples.

Results: Overall, there were no consistent differences in the way that the candidate IS (11/234), the IRR (75/502), and the two serum samples behaved in the assays with respect to linearity and parallelism. The mean IgE value of the candidate IS, 11/234, relative to the IRR, 75/502, was 13,411 IU/mL based on parallel line analysis of raw assay data at NIBSC, and 13,551 IU/mL based on the laboratories’ own estimates after correcting for the values obtained for 75/502.

Conclusions: The use of 11/234 will ensure that assays for serum IgE continue to be well standardised. The preparation was established by the WHO Expert Committee on Biological Standardization as the 3rd IS for serum IgE with an assigned value of 13,500 IU/mL, corresponding to 6750 IU/ampoule.


Corresponding author: Susan J. Thorpe, Biotherapeutics Group, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare Products Regulatory Agency, Blanche Lane, South Mimms, Potters Bar, Hertsfordshire EN6 3QG, UK, Fax: +44 1707 641057, E-mail:

Acknowledgments

We thank the staff of the Centre for Biological Reference Materials, NIBSC, for lyophilising the serum IgE bulk and sample despatch.

We are extremely grateful to Dr. Svante Bohman, Phadia, Thermo Fisher Scientific, Sweden, for providing plasma, patients at the Northern General Hospital for donating blood, and the study participants for contributing data.

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research funding played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Appendix

Appendix 1

Participants of the collaborative study (in alphabetical order of country).

Fu Boqiang, National Institute of Metrology, China
George Mitis, Nicosia General Hospital, Cyprus
Cindy Søndersø Knudsen, Aarhus Universitetshospital, Denmark
Christelle Richard, Genclis, France
Alf Weimann, Euroimmun AG, Germany
Rüdiger Wahl, Omega Diagnostics GmbH, Germany
Peter Muench, Roche Diagnostics GmbH, Germany
Harald Althaus, Siemens Healthcare Diagnostics, Germany
Kafasi Nikolitsa, Laiko General Hospital, Greece
Zanoni Giovanna, Universitaria Integrata di Verona, Italy
Trude Torsnes, Fürst Medisisnsk Laboratorium, Norway
Sivagowri Kasinathan, SSHF Kristiansand, Norway
Svante Bohman, Phadia AB, Sweden
Nils Burman, Sunderby Hospital, Sweden
Matthew Bennett, Genesis Diagnostics Ltd., UK
Jackie Donovan, Royal Brompton Hospital, UK
Annette Adelmann and James Sackrison, Beckman Coulter Inc., USA
Mark Van Cleve and Rosalind Wei, Hycor Biomedical Inc., USA
Appendix 2

Methods used by participating laboratories.

Laboratory numberMethod (as reported by the laboratory)
1Phadia ImmunoCAP® Total IgE,
Phadia ImmunoCAP® Total IgE low range
2Phadia ImmunoCAP® 250
3ELISA
4Chemiluminescence method
5Nephelometry (Behring)
6Beckman Access 2 – total IgE
7AELISA – Radim
7BNephelometry BN Prospect, Siemens
8Phadia ImmunoCAP® 250
9Heterogeneous Immunoassay (Elecsys)
10Phadia ImmunoCAP® 1000
11Microtitre plate ELISA
12ELISA
13Roche Diagnostics, Cobas e601
14not stated
15Microtitre plate ELISA
16not stated
17ELISA
18FEIA (fluorescence enzyme immunoassay)

References

1. Rowe DS, Tackett L, Bennich H, Ishizaka K, Johansson SG, Anderson SG. A research standard for human serum immunoglobulin E. Bull World Health Organ 1970;45:609–11.Search in Google Scholar

2. WHO Expert Committee on Biological Standardization. World Health Organization technical report series 1973;530:10.Search in Google Scholar

3. Seagroatt V, Anderson SG. The second international reference preparation for human serum immunoglobulin E and the first British standard for human serum immunoglobulin E. J Biol Stand 1981;9:431–7.10.1016/S0092-1157(81)80034-0Search in Google Scholar

4. WHO Expert Committee on Biological Standardization. World Health Organization technical report series 1981;658:21.Search in Google Scholar

5. Hamilton RG. Proficiency survey-based evaluation of clinical total and allergen-specific IgE assay performance. Arch Pathol Lab Med 2010;134:975–82.10.5858/2009-0518-OA.1Search in Google Scholar PubMed

6. UK NEQAS Immunology, Immunochemistry & Allergy Annual_Report_2012_V1.pdf.Search in Google Scholar

7. Finney DJ. Statistical methods in biological assay, 3rd ed. London: Charles Griffin, 1978.Search in Google Scholar

8. Kirkwood TB. Geometric means and measures of dispersion. Biometrics 1979;35:908–9.Search in Google Scholar

9. Kirkwood TB. Predicting the stability of biological standards and products. Biometrics 1977;33:736–42.10.2307/2529472Search in Google Scholar

Received: 2014-3-5
Accepted: 2014-4-9
Published Online: 2014-5-7
Published in Print: 2014-9-1

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Red blood cell distribution width (RDW) and human pathology. One size fits all
  4. Reviews
  5. LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations
  6. C-reactive protein and migraine. Facts or speculations?
  7. Mini Review
  8. ABO blood group and von Willebrand factor: biological implications
  9. Genetics and Molecular Diagnostics
  10. Lactase persistence genotyping: rapid detection of seven sequence variants in a single tube with melting curve analyses
  11. General Clinical Chemistry and Laboratory Medicine
  12. The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation
  13. Improving CardioCheck PA analytical performance: three-year study
  14. Serum copeptin level predicts a rapid decrease of overhydration after kidney transplantation
  15. Thyroid function and thyroid autoimmunity in apparently healthy pregnant and non-pregnant Mexican women
  16. Serum and follicular fluid fetuin-A in women undergoing in vitro fertilization
  17. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients
  18. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome
  19. Reference Values and Biological Variations
  20. Serum glucose adjusted cut-off values for normal cerebrospinal fluid/serum glucose ratio: implications for clinical practice
  21. Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care
  22. Cancer Diagnostics
  23. Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer
  24. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients
  25. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma
  26. Cardiovascular Diseases
  27. Ideal cardiovascular health behaviors and factors and high sensitivity C-reactive protein: the Kailuan cross-sectional study in Chinese
  28. Letters to the Editor
  29. Red cell distribution width predicts chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism in a long-term follow-up
  30. Red blood cell distribution width is significantly associated with aging and gender
  31. Red blood cell distribution width: a potential prognostic index for liver disease?
  32. Serum folate and vitamin B12: does light really matter?
  33. Thalassemia diagnosis in a blood donor from a unique trimorphic red blood cell population observed in the recipient
  34. A preliminary study on serum proteomics in fibromyalgia syndrome
  35. First study of angiotensin converting enzyme in cystic fibrosis Tunisian patients
  36. FlashFISH™: a novel technique for rapid diagnosis of aneuploidies in dysmorphic neonates
  37. Determination of the amniotic fluid lecithin/sphingomyelin ratio using a pipette tip column with a cation-exchange resin and mass spectrometry
  38. Congress Abstracts
  39. 57th National Congress of the Hungarian Society of Laboratory Medicine
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0243/html
Scroll to top button